HUP0001311A3 - 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them - Google Patents
5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing themInfo
- Publication number
- HUP0001311A3 HUP0001311A3 HU0001311A HUP0001311A HUP0001311A3 HU P0001311 A3 HUP0001311 A3 HU P0001311A3 HU 0001311 A HU0001311 A HU 0001311A HU P0001311 A HUP0001311 A HU P0001311A HU P0001311 A3 HUP0001311 A3 HU P0001311A3
- Authority
- HU
- Hungary
- Prior art keywords
- dihydroquinoxaline
- aminoalkoxy
- diones
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 229940052760 dopamine agonists Drugs 0.000 title 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80132497A | 1997-02-18 | 1997-02-18 | |
| PCT/US1998/001170 WO1998035948A1 (en) | 1997-02-18 | 1998-01-13 | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0001311A2 HUP0001311A2 (hu) | 2001-05-28 |
| HUP0001311A3 true HUP0001311A3 (en) | 2001-07-30 |
Family
ID=25180799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001311A HUP0001311A3 (en) | 1997-02-18 | 1998-01-13 | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0963372A1 (de) |
| JP (1) | JP2001511805A (de) |
| KR (1) | KR20000071162A (de) |
| CN (1) | CN1248249A (de) |
| AR (1) | AR011669A1 (de) |
| AU (1) | AU722616B2 (de) |
| BR (1) | BR9807230A (de) |
| CA (1) | CA2278757A1 (de) |
| HU (1) | HUP0001311A3 (de) |
| IL (1) | IL131160A0 (de) |
| NZ (1) | NZ336971A (de) |
| TW (1) | TW434230B (de) |
| WO (1) | WO1998035948A1 (de) |
| ZA (1) | ZA981306B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329698B2 (en) | 2008-06-16 | 2012-12-11 | MERCK Patent Gesellschaft mit beschränkter Haftung | Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179551C (no) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| US4975430A (en) * | 1989-06-16 | 1990-12-04 | The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University | CNQX and its analogs as therapeutics for degenerative neural diseases |
| PT99864B (pt) * | 1990-12-21 | 1999-06-30 | Schering Ag | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| EP0647137B1 (de) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycinrezeptorantagonisten und ihre verwendung |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
| ES2169102T3 (es) * | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
-
1998
- 1998-01-13 HU HU0001311A patent/HUP0001311A3/hu unknown
- 1998-01-13 NZ NZ336971A patent/NZ336971A/xx unknown
- 1998-01-13 EP EP98903628A patent/EP0963372A1/de not_active Withdrawn
- 1998-01-13 CA CA002278757A patent/CA2278757A1/en not_active Abandoned
- 1998-01-13 AU AU60350/98A patent/AU722616B2/en not_active Ceased
- 1998-01-13 KR KR1019997007452A patent/KR20000071162A/ko not_active Application Discontinuation
- 1998-01-13 WO PCT/US1998/001170 patent/WO1998035948A1/en not_active Application Discontinuation
- 1998-01-13 IL IL13116098A patent/IL131160A0/xx unknown
- 1998-01-13 JP JP53574298A patent/JP2001511805A/ja active Pending
- 1998-01-13 BR BR9807230-7A patent/BR9807230A/pt not_active Application Discontinuation
- 1998-01-13 CN CN98802636A patent/CN1248249A/zh active Pending
- 1998-02-05 TW TW087101493A patent/TW434230B/zh active
- 1998-02-11 AR ARP980100618A patent/AR011669A1/es unknown
- 1998-02-17 ZA ZA9801306A patent/ZA981306B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0001311A2 (hu) | 2001-05-28 |
| CA2278757A1 (en) | 1998-08-20 |
| AU6035098A (en) | 1998-09-08 |
| TW434230B (en) | 2001-05-16 |
| ZA981306B (en) | 1999-08-17 |
| EP0963372A1 (de) | 1999-12-15 |
| KR20000071162A (ko) | 2000-11-25 |
| JP2001511805A (ja) | 2001-08-14 |
| BR9807230A (pt) | 2000-04-25 |
| NZ336971A (en) | 2000-10-27 |
| AR011669A1 (es) | 2000-08-30 |
| CN1248249A (zh) | 2000-03-22 |
| WO1998035948A1 (en) | 1998-08-20 |
| AU722616B2 (en) | 2000-08-10 |
| IL131160A0 (en) | 2001-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100101A3 (en) | Prostaglandin agonists, pharmaceutical compositions comprising thereof and their use | |
| HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
| HUP0201545A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
| ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
| HUP0001539A3 (en) | 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same | |
| ZA9811759B (en) | Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them. | |
| IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0003217A3 (en) | Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and pharmaceutical compositions containing them | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| HUP9902455A3 (en) | 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them | |
| IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
| AU5460598A (en) | Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists | |
| HUP0102483A3 (en) | Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol | |
| AU6120498A (en) | 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| ZA9710593B (en) | Antisebum and antioxidant compositions containing gugulipid and fractions thereof. | |
| HUP0203505A3 (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0000762A3 (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them | |
| HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
| HK1036974A1 (en) | Indole derivatives and medicinal compositions containing the same. | |
| HUP0105075A3 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them | |
| HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof |